Sfoglia per AUTORE
CATTANEO CI
Collezione ASL Novara

  

Items : 14

Synthesising 30 years of clinical experience and scientific insight on affective temperaments in psychiatric disorders: State of the art. in Journal of affective disorders / J Affect Disord. 2024 Oct 1;362:406-415. doi: 10.1016/j.jad.2024.07.011. Epub 2024 Jul 5.
2024
ASL Novara
ASL Cuneo 2
ASL Biella

Favaretto E; Bedani F; Brancati GE; De Berardis D; Giovannini S; Scarcella L; Martiadis V; Martini A; Pampaloni I; Perugi G; Pessina E; Raffone F; Ressico F; Cattaneo CI;

Cariprazine Augmentation in Treatment-Resistant Bipolar Depression: Data from a Retrospective Observational Study. in Current neuropharmacology / Curr Neuropharmacol. 2024;22(10):1742-1748. doi: 10.2174/1570159X22666240129095852.
2024
ASL Cuneo 2
ASL Novara
AOU San Luigi di Orbassano

Rosso G; Martiadis V; Maina G; De Berardis D; Martini A; Cattaneo CI; Pessina E; Teobaldi E;

Efficacy and safety of selegiline across different psychiatric disorders: A systematic review and meta-analysis of oral and transdermal formulations. in European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology / Eur Neuropsychopharmacol. 2023 Jul;72:60-78. doi: 10.1016/j.euroneuro.2023.03.012. Epub 2023 Apr 21.
2023
ASL Novara

Iasevoli F; Ruhé HG; Stahl S; Van den Eynde V; Birkenhager TK; Cattaneo CI; Gillman K; Fornaro M; Zotti N; Vellucci A; Solini N; Sobrino A; Rossano F; Caiazza C; de Bartolomeis A;

Antidepressant discontinuation syndrome: A state-of-the-art clinical review. in European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology / Eur Neuropsychopharmacol. 2023 Jan;66:1-10. doi: 10.1016/j.euroneuro.2022.10.005. Epub 2022 Nov 4.
2023
ASL Novara

Fornaro M; Cattaneo CI; De Berardis D; Ressico FV; Martinotti G; Vieta E;

The shocking attitude toward electroconvulsive therapy in Italy. in CNS spectrums / CNS Spectr. 2022 Apr;27(2):131-133. doi: 10.1017/S1092852920002059. Epub 2020 Dec 4.
2022
ASL Novara

Fazzari G; Cattaneo CI; Fornaro M; Ressico F; Perugi G;

2021
ASL Novara

Cuomo A; Chioccioli M; Cattaneo CI; Magnani PA; Bussolotti D; Larcinese R; Bruni A; Torti C; Fagiolini A;

Commentary letter on "Revitalizing monoamine oxidase inhibitors: a call for action". in CNS spectrums / CNS Spectr. 2020 Aug;25(4):458-459. doi: 10.1017/S1092852919001378. Epub 2019 Oct 30.
2020
ASL Novara

Cattaneo CI; Fornaro M; Ressico FV; Perugi G;

Brexpiprazole for treatment-resistant major depressive disorder. in Expert opinion on pharmacotherapy / Expert Opin Pharmacother. 2019 Nov;20(16):1925-1933. doi: 10.1080/14656566.2019.1654457. Epub 2019 A
2019
ASL Novara

De Berardis D; Anastasia A; Fornaro M; Fusco A; Cattaneo CI;

Commentary on chronic mood instability: Bipolar, borderline or both? in Bipolar disorders / Bipolar Disord. 2019 Aug;21(5):460-461. doi: 10.1111/bdi.12774. Epub 2019 Apr 7.
2019
ASL Novara

Perugi G; Cattaneo CI; Ressico FV; Pallucchini A;

Vortioxetine exerts anti-inflammatory and immunomodulatory effects on human monocytes/macrophages. in British journal of pharmacology / Br J Pharmacol. 2018 Jan;175(1):113-124. doi: 10.1111/bph.14074. Epub 2017 Nov 28.
2018
ASL Novara

Talmon M; Rossi S; Pastore A; Cattaneo CI; Brunelleschi S; Fresu LG;

2017
ASL Novara

Ressico F; Valsesia R; D'Innella P; Cattaneo CI; Ballabio M; Fornaro M;

2016
ASL Biella
ASL VCO
ASL Novara

Zeppetell E; Trimarchi A; Geda G; Lembo F; Saglietti G; Lenz PFCC; Vozza S; Ficili B; Ferrari R; Figliolino M; Caruso G; Cattaneo CI;

Neurokinin (NK)-1 receptor expression in monocytes from bipolar disorder patients: a pilot study. in Journal of affective disorders / J Affect Disord. 2015 Jun 1;178:188-92. doi: 10.1016/j.jad.2015.03.013. Epub 2015 Mar 14.
2015
ASL Novara

Amoruso A; Bardelli C; Cattaneo CI; Fresu LG; Manzetti E; Brunelleschi S;

2011
ASL Novara

Cattaneo CI; Verde A; Castignoli G;